ISTH evaluation form Survey

Question Title

* 1. How useful for your professional activity did you find this symposium?

Extremely useful

Useful

Fairly useful

Not useful

If this activity was not useful, please explain why.

Question Title

* 2. What was your overall impression of this symposium?

	Excellent	Good	Fairly good	Poor	Very poor
Programme	Programme Excellent	Programme Good	Programme Fairly good	Programme Poor	Programme Very poor
Organisation	Organisation Excellent	Organisation Good	Organisation Fairly good	Organisation Poor	Organisation Very poor

Question Title

* 3. Did the symposium fulfil your educational goals and expected learning outcomes?

	Very much	Somewhat	Not much	Not at all	Undecided
Explain the advances in the understanding of hemophilia and other bleeding disorders	Explain the advances in the understanding of hemophilia and other bleeding disorders Very much	Explain the advances in the understanding of hemophilia and other bleeding disorders Somewhat	Explain the advances in the understanding of hemophilia and other bleeding disorders Not much	Explain the advances in the understanding of hemophilia and other bleeding disorders Not at all	Explain the advances in the understanding of hemophilia and other bleeding disorders Undecided
Compare new and emerging treatment options and their therapeutic targets	Compare new and emerging treatment options and their therapeutic targets Very much	Compare new and emerging treatment options and their therapeutic targets Somewhat	Compare new and emerging treatment options and their therapeutic targets Not much	Compare new and emerging treatment options and their therapeutic targets Not at all	Compare new and emerging treatment options and their therapeutic targets Undecided
Interpret the clinical implications of the latest anti-TFPI trial data	Interpret the clinical implications of the latest anti-TFPI trial data Very much	Interpret the clinical implications of the latest anti-TFPI trial data Somewhat	Interpret the clinical implications of the latest anti-TFPI trial data Not much	Interpret the clinical implications of the latest anti-TFPI trial data Not at all	Interpret the clinical implications of the latest anti-TFPI trial data Undecided

Question Title

* 4. Was the presented information well balanced and consistently supported by a valid scientific evidence base?

Very much

Somewhat

Not much

Not at all

Undecided

Question Title

* 5. How useful to you personally was each session?

	Extremely useful	Useful	Fairly useful	Not useful	Undecided/DNA
How has our current understanding of hemophilia driven new treatment options?	How has our current understanding of hemophilia driven new treatment options? Extremely useful	How has our current understanding of hemophilia driven new treatment options? Useful	How has our current understanding of hemophilia driven new treatment options? Fairly useful	How has our current understanding of hemophilia driven new treatment options? Not useful	How has our current understanding of hemophilia driven new treatment options? Undecided/DNA
What are these new treatment options?	What are these new treatment options? Extremely useful	What are these new treatment options? Useful	What are these new treatment options? Fairly useful	What are these new treatment options? Not useful	What are these new treatment options? Undecided/DNA
What do we know about anti-TFPI inhibitors?	What do we know about anti-TFPI inhibitors? Extremely useful	What do we know about anti-TFPI inhibitors? Useful	What do we know about anti-TFPI inhibitors? Fairly useful	What do we know about anti-TFPI inhibitors? Not useful	What do we know about anti-TFPI inhibitors? Undecided/DNA
Faculty discussion and audience questions	Faculty discussion and audience questions Extremely useful	Faculty discussion and audience questions Useful	Faculty discussion and audience questions Fairly useful	Faculty discussion and audience questions Not useful	Faculty discussion and audience questions Undecided/DNA

Question Title

* 6. Was there adequate time available for questions and answers and learner engagement?

Yes always/almost always

Yes, sometimes

Only rarely

Never

Undecided

Question Title

* 7. As a result of viewing this symposium, will you make any measurable changes in your role?

Yes

Possibly, after additional training

No, but the content affirms my current daily practice

No, I’m unable to implement the information

Undecided

If yes, can you provide ONE example how this event will influence your future practice?

If no, what are the barriers that prevent you from making changes?

Question Title

* 8. Did all the faculty members provide their potential conflict of interest declarations in their presentations?

Yes, all

Yes, for the majority

Yes, only a small part

Undecided/Don't know

Question Title

* 9. Do you agree that the information was overall free of commercial and other bias?

Strongly agree

Agree

Rather disagree

Strongly disagree

Undecided/Don't know

Can you provide an example of biased presentation in this activity?

ISTH evaluation form

Hopes and opportunities for hemophilia and other bleeding disorders

Question Title

* 1. How useful for your professional activity did you find this symposium?

Question Title

* 2. What was your overall impression of this symposium?

Question Title

* 3. Did the symposium fulfil your educational goals and expected learning outcomes?

Question Title

* 4. Was the presented information well balanced and consistently supported by a valid scientific evidence base?

Question Title

* 5. How useful to you personally was each session?

Question Title

* 6. Was there adequate time available for questions and answers and learner engagement?

Question Title

* 7. As a result of viewing this symposium, will you make any measurable changes in your role?

Question Title

* 8. Did all the faculty members provide their potential conflict of interest declarations in their presentations?

Question Title

* 9. Do you agree that the information was overall free of commercial and other bias?

Question Title

* 10. Do you have any final questions or comments?